PNAS:新发现或可破解精神类疾病发病机理

2012-12-12 PNAS PNAS

  最新一期的世界顶级学术期刊《美国国家科学院(PNAS)》发布了上海交大研究团队一项重要成果。上海交大系统生物医学研究院教授吴强的科研团队发现一种特殊蛋白质调控机理,阐明了原钙粘蛋白家族在大脑中细胞特异性表达的分子机制。这一研究成果对科学家破解人类基因组的编码调控机制,以及破解精神疾病发病机理将产生深远影响。   上海交大系统生物医学研究院教授吴强5日介绍,人脑含有上千亿个不同的神经细胞,每个

  最新一期的世界顶级学术期刊《美国国家科学院(PNAS)》发布了上海交大研究团队一项重要成果。上海交大系统生物医学研究院教授吴强的科研团队发现一种特殊蛋白质调控机理,阐明了原钙粘蛋白家族在大脑中细胞特异性表达的分子机制。这一研究成果对科学家破解人类基因组的编码调控机制,以及破解精神疾病发病机理将产生深远影响。

  上海交大系统生物医学研究院教授吴强5日介绍,人脑含有上千亿个不同的神经细胞,每个神经细胞又形成上万个特异性突触连接。如同世界上没有两片完全相同的树叶一样,人脑的神经细胞也各不相同,而构成其差异的“身份密码”就是由“原钙粘蛋白群”决定的。吴强说,如精神分裂症、自闭症、抑郁症,甚至脑肿瘤等大脑疾病,都可能是因为神经细胞某种蛋白质表达出现问题。如今这一“身份密码”如何产生得以破解,对于研究此类疾病机理将起到关键作用。

  吴强形容说,人的每个基因都有若干个激发其活性的“发动机”,称为“启动子”;还有一个增强其活性的“加速器”,称为“增强子”。在一条DNA染色体上,它们往往相隔甚远,它们如何自选组合决定了细胞的差异性,而它们如何选择、连结,是由“绝缘子结合蛋白CTCF”和“染色体粘连蛋白Cohesin”决定的。二者都至关重要,不可或缺,它们控制着原钙原蛋白“启动子”的选择,组成每个神经细胞独特的“身份密码”。

  国际评审专家对于该研究给予高度评价,认为其揭示的调控机制在基因表达调控领域具有广泛意义。专家认为,进一步的研究将有助于人们对复杂神经网络形成机理的理解,并促进对脑肿瘤、精神分裂症、自闭症等大脑疾病发病机制研究。     


Abstract
The closely linked human protocadherin (Pcdh) α, β, and γ gene clusters encode 53 distinct protein isoforms, which are expressed in a combinatorial manner to generate enormous diversity on the surface of individual neurons. This diversity is a consequence of stochastic promoter choice and alternative pre-mRNA processing. Here, we show that Pcdhα promoter choice is achieved by DNA looping between two downstream transcriptional enhancers and individual promoters driving the expression of alternate Pcdhα isoforms. In addition, we show that this DNA looping requires specific binding of the CTCF/cohesin complex to two symmetrically aligned binding sites in both the transcriptionally active promoters and in one of the enhancers. These findings have important implications regarding enhancer/promoter interactions in the generation of complex Pcdh cell surface codes for the establishment of neuronal identity and self-avoidance in individual neurons.

精神疾病相关的拓展阅读:
              

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1973823, encodeId=eafc19e38235b, content=<a href='/topic/show?id=77793e918a2' target=_blank style='color:#2F92EE;'>#发病机理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37918, encryptionId=77793e918a2, topicName=发病机理)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Fri May 24 06:55:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855343, encodeId=ba3418553430c, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Tue Aug 06 06:55:00 CST 2013, time=2013-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921083, encodeId=c9d519210837f, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Thu May 23 12:55:00 CST 2013, time=2013-05-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1973823, encodeId=eafc19e38235b, content=<a href='/topic/show?id=77793e918a2' target=_blank style='color:#2F92EE;'>#发病机理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37918, encryptionId=77793e918a2, topicName=发病机理)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Fri May 24 06:55:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855343, encodeId=ba3418553430c, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Tue Aug 06 06:55:00 CST 2013, time=2013-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921083, encodeId=c9d519210837f, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Thu May 23 12:55:00 CST 2013, time=2013-05-23, status=1, ipAttribution=)]
    2013-08-06 drwjr
  3. [GetPortalCommentsPageByObjectIdResponse(id=1973823, encodeId=eafc19e38235b, content=<a href='/topic/show?id=77793e918a2' target=_blank style='color:#2F92EE;'>#发病机理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37918, encryptionId=77793e918a2, topicName=发病机理)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Fri May 24 06:55:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1855343, encodeId=ba3418553430c, content=<a href='/topic/show?id=f32014428fc' target=_blank style='color:#2F92EE;'>#PNAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14428, encryptionId=f32014428fc, topicName=PNAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e964, createdName=drwjr, createdTime=Tue Aug 06 06:55:00 CST 2013, time=2013-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1921083, encodeId=c9d519210837f, content=<a href='/topic/show?id=6bfa58133ef' target=_blank style='color:#2F92EE;'>#新发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58133, encryptionId=6bfa58133ef, topicName=新发现)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644e456, createdName=vera_1203, createdTime=Thu May 23 12:55:00 CST 2013, time=2013-05-23, status=1, ipAttribution=)]

相关资讯

2010年中国科技论文统计出炉,生物医药领域表现不俗

中国科技信息研究所(下称中信所)12月2日对外发布了2010年中国科技论文(下称国际论文)统计结果。 2010年,我国机构作者为第一作者发表的国际论文共12.15万篇,其中23968篇论文的被引用次数高于学科均线,即其论文发表后的影响超过其所在学科的一般水平,也就是说占我国论文总数的19.7%的论文表现不俗,该比例较2009年的15.5%上升了4.2个百分点。我国表现不俗的论文 81.6%由